CatalystPit

PHVSPharvaris N.V.

NASDAQ · Pharmaceutical Preparations
Last close $31.72 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryPharmaceutical Preparations
RECENT INSIDER TRADES
  • 2026-09-25 · Monges Viviane (Director) · SELL
  • 2026-09-25 · Monges Viviane (Director) · OTHER
  • 2026-09-24 · Schikan Johannes Gerardus Christiaan Petrus (Director) · OTHER
  • 2026-09-24 · Schikan Johannes Gerardus Christiaan Petrus (Director) · SELL
  • 2026-09-24 · Lu Peng (President) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders130
Shares held64,630,465
Value$2.22B
Percent of shares outstanding99.11%
As of quarter end2026-06-30
RECENT NEWS
  • PHVS: Phase 3 Study Results Highlighting Deucrictibant’s Rapid and Sustained Efficacy in Treating HAE Attacks Published in The Lancet
  • Pharvaris presents at Morgan Stanley 24th Annual Global Healthcare Conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
Pharvaris N.V. (PHVS) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit